Synergy between PI3K/Akt and Raf/MEK/ERK Pathways in IGF-1R Mediated Cell Cycle Progression and Prevention of Apoptosis in Hematopoietic Cells
暂无分享,去创建一个
[1] J. McCubrey,et al. B-Raf and Insulin Synergistically Prevent Apoptosis and Induce Cell Cycle Progression in Hematopoietic Cell , 2004, Cell cycle.
[2] F. E. Bertrand,et al. JAK/STAT, Raf/MEK/ERK, PI3K/Akt and BCR-ABL in cell cycle progression and leukemogenesis , 2004, Leukemia.
[3] J. McCubrey,et al. Differential effects of kinase cascade inhibitors on neoplastic and cytokine-mediated cell proliferation , 2003, Leukemia.
[4] J. McCubrey,et al. Signal transduction mediated by the Ras/Raf/MEK/ERK pathway from cytokine receptors to transcription factors: potential targeting for therapeutic intervention , 2003, Leukemia.
[5] J. McCubrey,et al. Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy , 2003, Leukemia.
[6] J. McCubrey,et al. Targeting the Raf kinase cascade in cancer therapy – novel molecular targets and therapeutic strategies , 2002, Expert opinion on therapeutic targets.
[7] J. McCubrey,et al. Raf-Induced Cell Cycle Progression in Human TF-1 Hematopoietic Cells , 2002, Cell cycle.
[8] K. M. Nicholson,et al. The protein kinase B/Akt signalling pathway in human malignancy. , 2002, Cellular signalling.
[9] W. Fiedler,et al. Expression of a mutated form of the p85α regulatory subunit of phosphatidylinositol 3-kinase in a Hodgkin's lymphoma-derived cell line (CO) , 2002, Leukemia.
[10] J. McCubrey,et al. The Raf/MEK/ERK signal transduction cascade as a target for chemotherapeutic intervention in leukemia , 2002, Leukemia.
[11] P. Doshi,et al. Extracellular signal-regulated kinase and p38 mitogen-activated protein kinase pathways cooperate in mediating cytokine-induced proliferation of a leukemic cell line , 2002, Leukemia.
[12] G. G. Choudhury. Akt Serine Threonine Kinase Regulates Platelet-derived Growth Factor-induced DNA Synthesis in Glomerular Mesangial Cells , 2001, The Journal of Biological Chemistry.
[13] M. Mann,et al. p70S6 kinase signals cell survival as well as growth, inactivating the pro-apoptotic molecule BAD , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[14] J. McCubrey,et al. Enhanced ability of daniplestim and myelopoietin-1 to suppress apoptosis in human hematopoietic cells , 2001, Leukemia.
[15] J. McCubrey,et al. P21Cip1 induced by Raf is associated with increased Cdk4 activity in hematopoietic cells , 2001, Oncogene.
[16] J. McCubrey,et al. Suppression of apoptosis: role in cell growth and neoplasia , 2001, Leukemia.
[17] M. J. Fry. Phosphoinositide 3-kinase signalling in breast cancer: how big a role might it play? , 2001, Breast Cancer Research.
[18] J. McCubrey,et al. Synergistic effects of pi3k/akt on abrogation of cytokine-dependency induced by oncogenic raf. , 2001, Advances in enzyme regulation.
[19] J. McCubrey,et al. Effects of inducible MEK1 activation on the cytokine dependency of lymphoid cells , 2001, Leukemia.
[20] Ulf R. Rapp,et al. Apoptosis Suppression by Raf-1 and MEK1 Requires MEK- and Phosphatidylinositol 3-Kinase-Dependent Signals , 2001, Molecular and Cellular Biology.
[21] I. Leuschner,et al. Overexpression of phosphatidylinositol 3-kinase in human lung cancer , 2001, Langenbeck’s Archives of Surgery.
[22] T. Shimizu,et al. Complex regulation of CDK2 and G1 arrest during neuronal differentiation of human prostatic cancer TSU-Prl cells by staurosporine. , 2001, Anticancer research.
[23] J. McCubrey,et al. Interactions between the PI3K and Raf signaling pathways can result in the transformation of hematopoietic cells. , 2001, Cancer detection and prevention.
[24] J. Lammers,et al. Forkhead Transcription Factor FKHR-L1 Modulates Cytokine-Dependent Transcriptional Regulation of p27KIP1 , 2000, Molecular and Cellular Biology.
[25] M. Lawlor,et al. Insulin-Like Growth Factor-Mediated Muscle Cell Survival: Central Roles for Akt and Cyclin-Dependent Kinase Inhibitor p21 , 2000, Molecular and Cellular Biology.
[26] J. McCubrey,et al. Kinases: positive and negative regulators of apoptosis , 2000, Leukemia.
[27] A. Tolkovsky,et al. Phosphorylation of the pro-apoptotic protein BAD on serine 155, a novel site, contributes to cell survival , 2000, Current Biology.
[28] J. McCubrey,et al. Effects of deregulated RAF and MEK1 expression on the cytokine-dependency of hematopoietic cells. , 2000, Advances in enzyme regulation.
[29] J. McCubrey,et al. Synergy between Raf and BCL2 in abrogating the cytokine dependency of hematopoietic cells , 2000, Leukemia.
[30] J. McCubrey,et al. Combined effects of aberrant MEK1 activity and BCL2 overexpression on relieving the cytokine dependency of human and murine hematopoietic cells , 2000, Leukemia.
[31] D. B. Evans,et al. The N-terminal domains of cyclin-dependent kinase inhibitory proteins block the phosphorylation of cdk2/Cyclin E by the CDK-activating kinase. , 2000, Biochemical and biophysical research communications.
[32] R. Medema,et al. AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1 , 2000, Nature.
[33] M. Martínez-Lorenzo,et al. Tyrosine phosphorylation of the p85 subunit of phosphatidylinositol 3-kinase correlates with high proliferation rates in sublines derived from the Jurkat leukemia. , 2000, The international journal of biochemistry & cell biology.
[34] J. McCubrey,et al. Differential abilities of the Raf family of protein kinases to abrogate cytokine dependency and prevent apoptosis in murine hematopoietic cells by a MEK1-dependent mechanism , 2000, Leukemia.
[35] J. McCubrey,et al. A conditionally-active form of MEK1 results in autocrine transformation of human and mouse hematopoietic cells , 2000, Oncogene.
[36] J. McCubrey,et al. Serine/threonine phosphorylation in cytokine signal transduction , 2000, Leukemia.
[37] B. Calabretta,et al. Multiple Signaling Pathways of the Insulin-Like Growth Factor 1 Receptor in Protection from Apoptosis , 1999, Molecular and Cellular Biology.
[38] J. McCubrey,et al. Signal transduction, cell cycle regulatory, and anti-apoptotic pathways regulated by IL-3 in hematopoietic cells: possible sites for intervention with anti-neoplastic drugs , 1999, Leukemia.
[39] J. Downward,et al. Multiple Ras Effector Pathways Contribute to G1Cell Cycle Progression* , 1999, The Journal of Biological Chemistry.
[40] R. Adam,et al. The phosphatidylinositol 3'-kinase pathway is a dominant growth factor-activated cell survival pathway in LNCaP human prostate carcinoma cells. , 1999, Cancer research.
[41] James M. Roberts,et al. CDK inhibitors: positive and negative regulators of G1-phase progression. , 1999, Genes & development.
[42] B. Calabretta,et al. Activation of mitochondrial Raf-1 is involved in the antiapoptotic effects of Akt. , 1999, Cancer research.
[43] M. Greenberg,et al. Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor , 1999, Cell.
[44] M. Herlyn,et al. Contribution of phosphatidylinositol 3‐kinase to radiation resistance in human melanoma cells , 1999, Molecular carcinogenesis.
[45] J. McCubrey,et al. Differential abilities of activated Raf oncoproteins to abrogate cytokine dependency, prevent apoptosis and induce autocrine growth factor synthesis in human hematopoietic cells , 1998, Leukemia.
[46] Kenneth M. Yamada,et al. Tumor Suppressor PTEN Inhibits Integrin- and Growth Factor–mediated Mitogen-activated Protein (MAP) Kinase Signaling Pathways , 1998, The Journal of cell biology.
[47] R. Kolesnick,et al. BAD Enables Ceramide to Signal Apoptosis via Ras and Raf-1* , 1998, The Journal of Biological Chemistry.
[48] M. Wigler,et al. The lipid phosphatase activity of PTEN is critical for its tumor supressor function. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[49] N. Rosen,et al. Cyclin D Expression Is Controlled Post-transcriptionally via a Phosphatidylinositol 3-Kinase/Akt-dependent Pathway* , 1998, The Journal of Biological Chemistry.
[50] José Luis de la Pompa,et al. Negative Regulation of PKB/Akt-Dependent Cell Survival by the Tumor Suppressor PTEN , 1998, Cell.
[51] B. Calabretta,et al. Expression of Constitutively Active Raf-1 in the Mitochondria Restores Antiapoptotic and Leukemogenic Potential of a Transformation-deficient BCR/ABL Mutant , 1998, The Journal of experimental medicine.
[52] Tomohiko Maehama,et al. The Tumor Suppressor, PTEN/MMAC1, Dephosphorylates the Lipid Second Messenger, Phosphatidylinositol 3,4,5-Trisphosphate* , 1998, The Journal of Biological Chemistry.
[53] S. Brüsselbach,et al. Abrogation of c-Raf expression induces apoptosis in tumor cells , 1998, Oncogene.
[54] H. Abboud,et al. PI-3-kinase and MAPK regulate mesangial cell proliferation and migration in response to PDGF. , 1997, American journal of physiology. Renal physiology.
[55] S. R. Datta,et al. Akt Phosphorylation of BAD Couples Survival Signals to the Cell-Intrinsic Death Machinery , 1997, Cell.
[56] E. Lees,et al. Raf-induced proliferation or cell cycle arrest is determined by the level of Raf activity with arrest mediated by p21Cip1 , 1997, Molecular and cellular biology.
[57] M. Wigler,et al. PTEN, a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate Cancer , 1997, Science.
[58] A. Lloyd,et al. Cooperating oncogenes converge to regulate cyclin/cdk complexes. , 1997, Genes & development.
[59] G. Evan,et al. Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB , 1997, Nature.
[60] John Calvin Reed,et al. Bcl-2 Targets the Protein Kinase Raf-1 to Mitochondria , 1996, Cell.
[61] L. Neckers,et al. Taxol-induced apoptosis and phosphorylation of Bcl-2 protein involves c-Raf-1 and represents a novel c-Raf-1 signal transduction pathway. , 1996, Cancer research.
[62] F. Dumont,et al. Mechanism of action of the immunosuppressant rapamycin. , 1995, Life sciences.
[63] L. Neckers,et al. Taxol induction of p21WAF1 and p53 requires c-raf-1. , 1995, Cancer research.
[64] S. Elledge,et al. Inhibition of cyclin-dependent kinases by p21. , 1995, Molecular biology of the cell.
[65] K Y Hui,et al. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). , 1994, The Journal of biological chemistry.
[66] David Beach,et al. p21 is a universal inhibitor of cyclin kinases , 1993, Nature.
[67] A. Arcaro,et al. Wortmannin is a potent phosphatidylinositol 3-kinase inhibitor: the role of phosphatidylinositol 3,4,5-trisphosphate in neutrophil responses. , 1993, The Biochemical journal.
[68] J. McCubrey,et al. Growth-promoting effects of insulin-like growth factor-1 (IGF-1) on hematopoietic cells: overexpression of introduced IGF-1 receptor abrogates interleukin-3 dependency of murine factor-dependent cells by a ligand-dependent mechanism. , 1991, Blood.